Table 2.
Baseline characteristics of the participants according to the sex groups.
| Total | Female | Male | P-value | |
|---|---|---|---|---|
| N | 601 | 159 | 442 | – |
| Age (year) | 39.44 ± 13.37 | 39.24 ± 13.87 | 39.51 ± 13.20 | 0.833 |
| WC (cm) | 84.99 ± 10.96 | 82.44 ± 10.79 | 86.08 ± 10.88 | 0.001 |
| HC (cm) | 92.13 ± 8.54 | 91.52 ± 8.75 | 92.39 ± 8.45 | 0.323 |
| BMI (kg/m2) | 24.55 ± 3.74 | 24.43 ± 4.46 | 24.59 ± 3.45 | 0.637 |
| SBP (mmHg) | 126.16 ± 15.51 | 123.92 ± 17.57 | 126.96 ± 14.64 | 0.034 |
| DBP (mmHg) | 82.09 ± 10.04 | 88.93 ± 10.68 | 82.50 ± 9.78 | 0.091 |
| FBG (mmol/L) | 6.99 ± 3.66 | 7.77 ± 4.07 | 6.71 ± 3.48 | 0.002 |
| TG (mg/dL) | 187.31 ± 114.21 | 171.09 ± 124.68 | 193.11 ± 109.81 | 0.046 |
| TC (mg/dL) | 201.42 ± 73.02 | 215.34 ± 86.71 | 197.14 ± 67.81 | 0.019 |
| HDL-C (mg/dL) | 33.48 ± 12.16 | 36.61 ± 10.06 | 32.52 ± 12.59 | 0.002 |
| LDL-C (mg/dL) | 133.34 ± 66.31 | 151.01 ± 83.71 | 127.90 ± 59.02 | 0.001 |
| XO (U/L) | 4.62 ± 3.24 | 6.17 ± 3.77 | 4.00 ± 2.77 | 0.000 |
| SUA (mg/dL) | 5.91 ± 1.94 | 4.82 ± 1.92 | 6.29 ± 1.79 | 0.034 |
| MetS (%) | 45.1 | 45.9 | 44.8 | 0.853 |
| Hyperuricemia (%) | 27.6 | 19.5 | 30.5 | 0.008 |
| Diabetes (%) | 37.5 | 53.8 | 31.7 | 0.000 |
| Hypertension (%) | 39.7 | 40.3 | 39.5 | 0.860 |
| Physical activity (%) | ||||
| Low | 23.3 | 31.6 | 18.3 | 0.002 |
| Moderate/adequate | 77.7 | 68.4 | 81.7 | 0.003 |
| Smoking (%) | ||||
| Yes | 21.1 | 0.0 | 28.7 | 0.000 |
| No | 78.9 | 100.0 | 71.3 | 0.000 |
MetS: Metabolic Syndrome. Values are presented as mean ± SD. P-values for continuous and categorical variables are obtained from independent sample t-test and chi-square test, respectively.